Golimumab
Simponi (golimumab) is a prescription medication manufactured by Janssen Biotech, Inc., used as a tumor necrosis factor (TNF) blocker to treat inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It comes as a subcutaneous injection in prefilled syringes containing 100 mg/mL solution. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Simponi (golimumab) is a prescription medication manufactured by Janssen Biotech, Inc., used as a tumor necrosis factor (TNF) blocker to treat inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It comes as a subcutaneous injection in prefilled syringes containing 100 mg/mL solution. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Golimumab",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Golimumab — ANDA 125289 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125289"
}
]
|
| identifier | ANDA125289 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"health-care",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Golimumab |
